Costs and Expenses in USD of Aurinia Pharmaceuticals Inc. from 2019 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
Aurinia Pharmaceuticals Inc. quarterly/annual Costs and Expenses history and change rate from 2019 to Q3 2025.
  • Aurinia Pharmaceuticals Inc. Costs and Expenses for the quarter ending September 30, 2025 was $43.7M, a 22% decline year-over-year.
  • Aurinia Pharmaceuticals Inc. Costs and Expenses for the twelve months ending September 30, 2025 was $196M, a 22.6% decline year-over-year.
  • Aurinia Pharmaceuticals Inc. annual Costs and Expenses for 2024 was $240M, a 10.2% decline from 2023.
  • Aurinia Pharmaceuticals Inc. annual Costs and Expenses for 2023 was $267M, a 8.84% increase from 2022.
  • Aurinia Pharmaceuticals Inc. annual Costs and Expenses for 2022 was $246M, a 8.47% increase from 2021.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Change (%)
Costs and Expenses, Annual (USD)
Costs and Expenses, YoY Annual Change (%)

Aurinia Pharmaceuticals Inc. Quarterly Costs and Expenses (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $196M $43.7M -$12.3M -22% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-04
Q2 2025 $208M $49.9M -$8.78M -15% Apr 1, 2025 Jun 30, 2025 10-Q 2025-07-31
Q1 2025 $217M $40.6M -$22.9M -36.1% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-12
Q4 2024 $240M $61.5M -$13.2M -17.7% Oct 1, 2024 Dec 31, 2024 10-K 2025-02-27
Q3 2024 $253M $56M -$14.8M -20.8% Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-04
Q2 2024 $268M $58.7M +$1.04M +1.81% Apr 1, 2024 Jun 30, 2024 10-Q 2025-07-31
Q1 2024 $267M $63.6M -$437K -0.68% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-12
Q4 2023 $267M $74.8M +$18.2M +32.3% Oct 1, 2023 Dec 31, 2023 10-K 2025-02-27
Q3 2023 $249M $70.8M +$5.5M +8.43% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 $243M $57.7M -$6.52M -10.2% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-01
Q1 2023 $250M $64M +$4.49M +7.54% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q4 2022 $246M $56.5M +$426K +0.76% Oct 1, 2022 Dec 31, 2022 10-K 2025-02-27
Q3 2022 $245M $65.3M +$258K +0.4% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 $245M $64.2M +$10.4M +19.4% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 $234M $59.5M +$8.05M +15.6% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 $226M $56.1M -$1.97M -3.4% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-15
Q3 2021 $228M $65M +$22.7M +53.6% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $206M $53.8M +$26.9M +99.9% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $179M $51.5M +$24.4M +89.9% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 $154M $58.1M Oct 1, 2020 Dec 31, 2020 10-K 2023-02-28
Q3 2020 $42.3M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-03
Q2 2020 $26.9M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $27.1M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06

Aurinia Pharmaceuticals Inc. Annual Costs and Expenses (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $240M -$27.4M -10.2% Jan 1, 2024 Dec 31, 2024 10-K 2025-02-27
2023 $267M +$21.7M +8.84% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-27
2022 $246M +$19.2M +8.47% Jan 1, 2022 Dec 31, 2022 10-K 2025-02-27
2021 $226M +$71.9M +46.6% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-15
2020 $154M +$63.1M +69.2% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-28
2019 $91.3M Jan 1, 2019 Dec 31, 2019 10-K 2022-02-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.